Latest Biodelivery Sciences International (BDSI) H
Post# of 40
Posted On: 03/12/2014 6:30:16 PM
Latest Biodelivery Sciences International (BDSI) Headlines
BioDelivery Sciences Has Returned 82.5% Since SmarTrend Recommendation (BDSI)
Comtex SmarTrend(R) - 47 mins ago
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 82.53% as of today's recent price of $9.51.
Equities Hitting New High: Allergan, Aetna, Ecolab, and BioDelivery Sciences Intl.
PR Newswire - Wed Mar 12, 11:17AM CDT
On Tuesday, March 11, 2014, the NASDAQ Composite finished at 4,307.19, down 0.63%. The Dow Jones Industrial Average closed the session at 16,351.25, down 0.41% and the S&P 500 ended the day at 1867.63, lower by 0.51%. The losses were broad based as nine out of ten sectors ended the session in negative. Investor-Edge.com looks at some of the equities that hit a new 52-week high during the last session. These include Allergan Inc. (NYSE:AGN), Aetna Inc. (NYSE:AET), Ecolab Inc. (NYSE:ECL), and BioDelivery Sciences International Inc. (NASDAQ:BDSI). Free research on these four companies can be accessed at:
BioDelivery Sciences Up 83.4% Since SmarTrend Uptrend Call (BDSI)
Comtex SmarTrend(R) - Wed Mar 05, 11:01AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 83.38% as of today's recent price of $9.55.
BioDelivery Sciences to Present at the 26th Annual ROTH Conference
PR Newswire - Wed Mar 05, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 26th Annual ROTH Conference. The presentation is scheduled for Monday, March 10, 2014 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) at the Ritz Carlton, Laguna Niguel in Dana Point, California.
BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference
PR Newswire - Fri Feb 28, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Cowen and Company 34th Annual Health Care Conference. The presentation is scheduled for Tuesday, March 4, 2014 at 8:40 a.m. Eastern Time at the Boston Marriott Copley Place.
5 Stocks Under $10 Setting Up to Soar
at The Street - Thu Feb 27, 12:54PM CST
These under-$10 stocks look ready to trade higher from current levels.
Uptrend Call Working As BioDelivery Sciences Stock Rises 70.9% (BDSI)
Comtex SmarTrend(R) - Wed Feb 26, 9:37AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 70.92% as of today's recent price of $8.91.
BioDelivery Sciences Shares Up 76.7% Since SmarTrend's Buy Recommendation (BDSI)
Comtex SmarTrend(R) - Wed Feb 19, 9:07AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 76.66% as of today's recent price of $9.20.
BioDelivery Sciences Closes $60 Million Registered Direct Offering
PR Newswire - Thu Feb 13, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that it has closed its previously announced registered direct offering with a select group of institutional investors under which such investors have purchased an aggregate of 7,500,000 shares of BDSI's common stock yielding gross proceeds of $60 million to BDSI.
BioDelivery Sciences Up 70.1% Since SmarTrend Uptrend Call (BDSI)
Comtex SmarTrend(R) - Tue Feb 11, 4:43PM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 2 months, BioDelivery Sciences has returned 70.06% as of today's recent price of $8.86.
BioDelivery Sciences International (BDSI) Jumps: Stock Up 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 8:39AM CST
BioDelivery Sciences International, Inc. was a big mover last session, as its shares rose nearly 9% on the day.
BioDelivery Sciences International Inc expects USD60m in registered direct offering with institutional investors
M2 - Tue Feb 11, 5:34AM CST
Pharmaceutical company BioDelivery Sciences International Inc (NasdaqCM:BDSI) said on Monday that it plans to sell USD60m of its common stock in a registered direct offering.
BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors
PR Newswire - Mon Feb 10, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced that it has entered into a definitive securities purchase agreement with a select group of institutional investors led by Federated Kaufmann under which such investors have committed to purchase $60 million of BDSI's common stock in a registered direct offering.
Shares of BDSI Up 49.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 04, 11:01AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 2 months, BioDelivery Sciences has returned 49.52% as of today's recent price of $7.79.
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference
PR Newswire - Thu Jan 30, 6:00AM CST
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today announced that data from clinical studies of BUNAVAIL have been accepted for presentation at the American Society of Addiction Medicine (ASAM) 45th Annual Medical-Scientific Conference, April 10-13, 2014 in Orlando, Florida.
Shares of BDSI Up 61.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 28, 9:36AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 2 months, BioDelivery Sciences has returned 61.80% as of today's recent price of $8.43.
1 Huge Health-Care Winner and 1 Big Pharma Loser From Last Week
David Williamson, The Motley Fool - Motley Fool - Mon Jan 27, 6:46PM CST
On Friday, shares of BioDelivery Sciences exploded, up a massive 36% in a single day after a successful phase 3 trial of a pain mitigation pill. This trial success triggers a $10 million milestone for the company and sets BioDelivery up for...
Nasdaq stocks posting largest percentage decreases
AP - Mon Jan 27, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BioDelivery Sciences International (BDSI) Soars: Stock Up 50.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 27, 7:51AM CST
BioDelivery Sciences International, Inc. was a big mover last session, as its shares rose almost 51% on the day.
BioDelivery Sciences Has Returned 82.5% Since SmarTrend Recommendation (BDSI)
Comtex SmarTrend(R) - 47 mins ago
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 82.53% as of today's recent price of $9.51.
Equities Hitting New High: Allergan, Aetna, Ecolab, and BioDelivery Sciences Intl.
PR Newswire - Wed Mar 12, 11:17AM CDT
On Tuesday, March 11, 2014, the NASDAQ Composite finished at 4,307.19, down 0.63%. The Dow Jones Industrial Average closed the session at 16,351.25, down 0.41% and the S&P 500 ended the day at 1867.63, lower by 0.51%. The losses were broad based as nine out of ten sectors ended the session in negative. Investor-Edge.com looks at some of the equities that hit a new 52-week high during the last session. These include Allergan Inc. (NYSE:AGN), Aetna Inc. (NYSE:AET), Ecolab Inc. (NYSE:ECL), and BioDelivery Sciences International Inc. (NASDAQ:BDSI). Free research on these four companies can be accessed at:
BioDelivery Sciences Up 83.4% Since SmarTrend Uptrend Call (BDSI)
Comtex SmarTrend(R) - Wed Mar 05, 11:01AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 83.38% as of today's recent price of $9.55.
BioDelivery Sciences to Present at the 26th Annual ROTH Conference
PR Newswire - Wed Mar 05, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 26th Annual ROTH Conference. The presentation is scheduled for Monday, March 10, 2014 at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) at the Ritz Carlton, Laguna Niguel in Dana Point, California.
BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference
PR Newswire - Fri Feb 28, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Cowen and Company 34th Annual Health Care Conference. The presentation is scheduled for Tuesday, March 4, 2014 at 8:40 a.m. Eastern Time at the Boston Marriott Copley Place.
5 Stocks Under $10 Setting Up to Soar
at The Street - Thu Feb 27, 12:54PM CST
These under-$10 stocks look ready to trade higher from current levels.
Uptrend Call Working As BioDelivery Sciences Stock Rises 70.9% (BDSI)
Comtex SmarTrend(R) - Wed Feb 26, 9:37AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 70.92% as of today's recent price of $8.91.
BioDelivery Sciences Shares Up 76.7% Since SmarTrend's Buy Recommendation (BDSI)
Comtex SmarTrend(R) - Wed Feb 19, 9:07AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 3 months, BioDelivery Sciences has returned 76.66% as of today's recent price of $9.20.
BioDelivery Sciences Closes $60 Million Registered Direct Offering
PR Newswire - Thu Feb 13, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that it has closed its previously announced registered direct offering with a select group of institutional investors under which such investors have purchased an aggregate of 7,500,000 shares of BDSI's common stock yielding gross proceeds of $60 million to BDSI.
BioDelivery Sciences Up 70.1% Since SmarTrend Uptrend Call (BDSI)
Comtex SmarTrend(R) - Tue Feb 11, 4:43PM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 2 months, BioDelivery Sciences has returned 70.06% as of today's recent price of $8.86.
BioDelivery Sciences International (BDSI) Jumps: Stock Up 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 8:39AM CST
BioDelivery Sciences International, Inc. was a big mover last session, as its shares rose nearly 9% on the day.
BioDelivery Sciences International Inc expects USD60m in registered direct offering with institutional investors
M2 - Tue Feb 11, 5:34AM CST
Pharmaceutical company BioDelivery Sciences International Inc (NasdaqCM:BDSI) said on Monday that it plans to sell USD60m of its common stock in a registered direct offering.
BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors
PR Newswire - Mon Feb 10, 6:00AM CST
BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced that it has entered into a definitive securities purchase agreement with a select group of institutional investors led by Federated Kaufmann under which such investors have committed to purchase $60 million of BDSI's common stock in a registered direct offering.
Shares of BDSI Up 49.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 04, 11:01AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 2 months, BioDelivery Sciences has returned 49.52% as of today's recent price of $7.79.
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference
PR Newswire - Thu Jan 30, 6:00AM CST
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today announced that data from clinical studies of BUNAVAIL have been accepted for presentation at the American Society of Addiction Medicine (ASAM) 45th Annual Medical-Scientific Conference, April 10-13, 2014 in Orlando, Florida.
Shares of BDSI Up 61.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 28, 9:36AM CST
SmarTrend identified an Uptrend for BioDelivery Sciences (NASDAQ:BDSI) on December 3rd, 2013 at $5.21. In approximately 2 months, BioDelivery Sciences has returned 61.80% as of today's recent price of $8.43.
1 Huge Health-Care Winner and 1 Big Pharma Loser From Last Week
David Williamson, The Motley Fool - Motley Fool - Mon Jan 27, 6:46PM CST
On Friday, shares of BioDelivery Sciences exploded, up a massive 36% in a single day after a successful phase 3 trial of a pain mitigation pill. This trial success triggers a $10 million milestone for the company and sets BioDelivery up for...
Nasdaq stocks posting largest percentage decreases
AP - Mon Jan 27, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BioDelivery Sciences International (BDSI) Soars: Stock Up 50.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 27, 7:51AM CST
BioDelivery Sciences International, Inc. was a big mover last session, as its shares rose almost 51% on the day.
(0)
(0)